A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer.
Pfohl U, Loskutov J, Bashir S, Kühn R, Herter P, Templin M, Mamlouk S, Belanov S, Linnebacher M, Bürtin F, Vetter M, Reinhard C, Wedeken L, Regenbrecht CRA.
Pfohl U, et al. Among authors: loskutov j.
Cancers (Basel). 2022 Jul 1;14(13):3252. doi: 10.3390/cancers14133252.
Cancers (Basel). 2022.
PMID: 35805024
Free PMC article.